Corticosteroids in Patients With COVID-19: What About the Control Group?
Clin Infect Dis
.
2021 Mar 15;72(6):1102-1103.
doi: 10.1093/cid/ciaa768.
Authors
Tomasz Chroboczek
1
,
Marie Lacoste
1
,
Chloe Wackenheim
1
,
Thibaut Challan-Belval
1
,
Benjamin Amar
2
,
Thomas Boisson
2
,
Jason Hubac
2
,
Dominique Leduc
1
,
Colleen Masse
1
,
Victor Dechaene
1
,
Laetitia Touihri-Maximin
1
,
Sandrine Megessier
1
,
Camille Lassale
3
4
Affiliations
1
Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Alpes Léman, Contamine sur Arve, France.
2
Service de Médecine Interne, Centre Hospitalier Alpes Léman, Contamine sur Arve, France.
3
Hospital del Mar Medical Research Institute, Barcelona, Spain.
4
Department of Epidemiology and Public Health, University College London, London, United Kingdom.
PMID:
32548616
PMCID:
PMC7337696
DOI:
10.1093/cid/ciaa768
No abstract available
Publication types
Letter
MeSH terms
Adrenal Cortex Hormones / therapeutic use
COVID-19*
Control Groups*
Humans
SARS-CoV-2
Substances
Adrenal Cortex Hormones